{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:21:55Z","timestamp":1789611715398,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s40620-014-0045-4","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T10:27:17Z","timestamp":1392028037000},"page":"181-186","source":"Crossref","is-referenced-by-count":17,"title":["Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease"],"prefix":"10.1093","volume":"27","author":[{"given":"Ismail","family":"Kocyigit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eray","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozcan","family":"Orscelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydin","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Gungor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahir","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Karakukcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Imamoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat Hayri","family":"Sipahioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Tokgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktay","family":"Oymak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"issue":"5","key":"45_CR1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199307293290508","volume":"329","author":"PA Gabow","year":"1993","unstructured":"Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329(5):332\u2013342","journal-title":"N Engl J Med"},{"issue":"2","key":"45_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3\u00a0years. Kidney Int 76(2):149\u2013168","journal-title":"Kidney Int"},{"issue":"4","key":"45_CR3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2009.13","volume":"5","author":"T Ecder","year":"2009","unstructured":"Ecder T, Schrier RW (2009) Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 5(4):221\u2013228","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"45_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","volume":"17","author":"AB Chapman","year":"2010","unstructured":"Chapman AB, Stepniakowski K, Rahbari-Oskoui F (2010) Hypertension in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 17(2):153\u2013163","journal-title":"Adv Chronic Kidney Dis"},{"issue":"7","key":"45_CR5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","volume":"42","author":"ME Widlansky","year":"2003","unstructured":"Widlansky ME, Gokce N, Keaney JF Jr, Vita JA (2003) The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42(7):1149\u20131160","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"45_CR6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.V1181371","volume":"11","author":"D Wang","year":"2000","unstructured":"Wang D, Iversen J, Strandgaard S (2000) Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11(8):1371\u20131376","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"45_CR7","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1523-1755.2003.00236.x","volume":"64","author":"D Wang","year":"2003","unstructured":"Wang D, Iversen J, Wilcox CS, Strandgaard S (2003) Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 64(4):1381\u20131388","journal-title":"Kidney Int"},{"issue":"1","key":"45_CR8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","volume":"6","author":"V Menon","year":"2011","unstructured":"Menon V, Rudym D, Chandra P, Miskulin D, Perrone R, Sarnak M (2011) Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol 6(1):7\u201313","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"45_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000101369","volume":"27","author":"ML Borresen","year":"2007","unstructured":"Borresen ML, Wang D, Strandgaard S (2007) Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am J Nephrol 27(3):240\u2013246","journal-title":"Am J Nephrol"},{"issue":"1","key":"45_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000339440","volume":"36","author":"I Kocyigit","year":"2012","unstructured":"Kocyigit I, Kaya MG, Orscelik O, Kaya C, Akpek M, Zengin H, Sipahioglu MH, Unal A, Yilmaz MI, Tokgoz B, Oymak O, Axelsson J (2012) Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients. Am J Nephrol 36(1):11\u201318","journal-title":"Am J Nephrol"},{"issue":"10","key":"45_CR11","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","volume":"84","author":"VV Alles","year":"1994","unstructured":"Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A (1994) Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 84(10):3483\u20133493","journal-title":"Blood"},{"issue":"2","key":"45_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosis.2004.03.020","volume":"175","author":"M Klouche","year":"2004","unstructured":"Klouche M, Peri G, Knabbe C, Eckstein HH, Schmid FX, Schmitz G, Mantovani A (2004) Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 175(2):221\u2013228","journal-title":"Atherosclerosis"},{"issue":"5","key":"45_CR13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.vph.2006.08.011","volume":"45","author":"A Mantovani","year":"2006","unstructured":"Mantovani A, Garlanda C, Bottazzi B, Peri G, Doni A, Martinez de la Torre Y, Latini R (2006) The long pentraxin PTX3 in vascular pathology. Vascul Pharmacol 45(5):326\u2013330","journal-title":"Vascul Pharmacol"},{"issue":"12","key":"45_CR14","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","volume":"44","author":"F Fazzini","year":"2001","unstructured":"Fazzini F, Peri G, Doni A, Dell\u2019Antonio G, Dal Cin E, Bozzolo E, D\u2019Auria F, Praderio L, Ciboddo G, Sabbadini MG, Manfredi AA, Mantovani A, Querini PR (2001) PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 44(12):2841\u20132850","journal-title":"Arthritis Rheum"},{"issue":"8","key":"45_CR15","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/ndt\/gfl747","volume":"22","author":"M Boehme","year":"2007","unstructured":"Boehme M, Kaehne F, Kuehne A, Bernhardt W, Schr\u00f6der M, Pommer W, Fischer C, Becker H, M\u00fcller C, Schindler R (2007) Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease. Nephrol Dial Transpl 22(8):2224\u20132229","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"45_CR16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.00870207","volume":"2","author":"M Tong","year":"2007","unstructured":"Tong M, Carrero JJ, Qureshi AR, Anderstam B, Heimb\u00fcrger O, B\u00e1r\u00e1ny P, Axelsson J, Alvestrand A, Stenvinkel P, Lindholm B, Suliman ME (2007) Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2(5):889\u2013897","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"45_CR17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2215\/CJN.03960907","volume":"3","author":"ME Suliman","year":"2008","unstructured":"Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimb\u00fcrger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P (2008) Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol 3(4):976\u2013985","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3\u20134","key":"45_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000353730","volume":"123","author":"I Kocyigit","year":"2013","unstructured":"Kocyigit I, Yilmaz MI, Orscelik O, Sipahioglu MH, Unal A, Eroglu E, Kalay N, Tokgoz B, Axelsson J, Oymak O (2013) Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease. Nephron Clin Pract 123(3\u20134):157\u2013164","journal-title":"Nephron Clin Pract"},{"issue":"1","key":"45_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1373\/clinchem.2005.0525144","volume":"52","author":"GL Myers","year":"2006","unstructured":"Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, Hostetter T, Levey AS, Panteghini M, Welch M, Eckfeldt JH, National Kidney Disease Education Program Laboratory Working Group (2006) Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52(1):5\u201318","journal-title":"Clin Chem"},{"issue":"3","key":"45_CR20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0735-1097(93)90203-D","volume":"22","author":"DS Celermajer","year":"1993","unstructured":"Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 22(3):854\u2013858","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"45_CR21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7326\/0003-4819-145-1-200607040-00129","volume":"145","author":"DM Lloyd-Jones","year":"2006","unstructured":"Lloyd-Jones DM, Liu K, Tian L, Greenland P (2006) Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145(1):35\u201342","journal-title":"Ann Intern Med"},{"issue":"2","key":"45_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","volume":"3","author":"P Stenvinkel","year":"2008","unstructured":"Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimb\u00fcrger O, Massy Z (2008) Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3(2):505\u2013521","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"45_CR23","doi-asserted-by":"crossref","first-page":"e1395","DOI":"10.1371\/journal.pone.0001395","volume":"3","author":"JK Pai","year":"2008","unstructured":"Pai JK, Mukamal KJ, Rexrode KM, Rimm EB (2008) C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS One 3(1):e1395","journal-title":"PLoS One"},{"issue":"4","key":"45_CR24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.09231010","volume":"6","author":"MI Yilmaz","year":"2011","unstructured":"Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz Y, Vural A, \u00c7akar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ (2011) Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol 6(4):785\u2013792","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"45_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hcn019","volume":"101","author":"ME Suliman","year":"2008","unstructured":"Suliman ME, Qureshi AR, Carrero JJ, B\u00e1r\u00e1ny P, Yilmaz MI, Snaedal-Jonsdottir S, Alvestrand A, Heimb\u00fcrger O, Lindholm B, Stenvinkel P (2008) The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. QJM 101(5):397\u2013405","journal-title":"QJM"},{"issue":"2","key":"45_CR26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ahj.2011.11.007","volume":"163","author":"R Dubin","year":"2012","unstructured":"Dubin R, Li Y, Ix JH, Shlipak MG, Whooley M, Peralta CA (2012) Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study. Am Heart J 163(2):274\u2013279","journal-title":"Am Heart J"},{"issue":"2","key":"45_CR27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2011.11.036","volume":"220","author":"WS Ryu","year":"2012","unstructured":"Ryu WS, Kim CK, Kim BJ, Kim C, Lee SH, Yoon BW (2012) Pentraxin 3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis 220(2):581\u2013586","journal-title":"Atherosclerosis"},{"issue":"3","key":"45_CR28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/HYPERTENSIONAHA.110.167015","volume":"57","author":"DJ Green","year":"2011","unstructured":"Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G (2011) Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter? Hypertension 57(3):363\u2013369","journal-title":"Hypertension"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0045-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0045-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0045-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:49Z","timestamp":1777564669000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/27\/2\/181\/8372192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0045-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}